Search Results - Yongfen Ma
- Showing 1 - 1 results of 1
-
1
A phase I randomized study to evaluate safety, pharmacokinetics, and pharmacodynamics of SIR2446M, a selective RIPK1 inhibitor, in healthy participants by Ana Liza Andresan Sun, John David Gillies, Yang Shen, Huajun Deng, Fenchao Xue, Yongfen Ma, Linan Song
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book